AIMS: To determine the prevalence of plasma vitamin D (25-dihydroxyvitamin D) insufficiency in individuals with Type 1 diabetes and to determine the cross-sectional and longitudinal associations of plasma vitamin D with insulin resistance. METHODS: Participants from the SEARCH for Diabetes in Youth Study [n = 1426; mean age 11.2 years (sd 3.9)] had physician-diagnosed Type 1 diabetes [diabetes duration mean 10.2 months (sd 6.5)] with data available at baseline and follow-up (approximately 12 and 24 months after baseline). Insulin resistance was estimated using a validated equation. Cross-sectional and longitudinal multivariate logistic regression models were used to determine the association of plasma vitamin D with insulin resistance, adjusting for potential confounders. RESULTS: Forty-nine per cent of individuals had plasma vitamin D < 50 nmol/l and 26% were insulin resistant. In cross-sectional multivariate analyses, participants who had higher plasma vitamin D (65 nmol/l) had lower odds of prevalent insulin resistance than participants with lower plasma vitamin D (25 nmol/l) (odds ratio 0.70, 95% CI 0.57-0.85). This association was attenuated after additional adjustment for BMI z-score, which could be a confounder or a mediator (odds ratio 0.81, 95% CI 0.64-1.03). In longitudinal multivariate analyses, individuals with higher plasma vitamin D at baseline had lower odds of incident insulin resistance, but this was not significant (odds ratio 0.85, 95% CI 0.63-1.14). CONCLUSIONS: Vitamin D insufficiency is common in individuals with Type 1 diabetes and may increase risk for insulin resistance. Additional prospective studies are needed to determine the association between plasma vitamin D and insulin resistance, and to further examine the role of adiposity on this association.
AIMS: To determine the prevalence of plasma vitamin D (25-dihydroxyvitamin D) insufficiency in individuals with Type 1 diabetes and to determine the cross-sectional and longitudinal associations of plasma vitamin D with insulin resistance. METHODS:Participants from the SEARCH for Diabetes in Youth Study [n = 1426; mean age 11.2 years (sd 3.9)] had physician-diagnosed Type 1 diabetes [diabetes duration mean 10.2 months (sd 6.5)] with data available at baseline and follow-up (approximately 12 and 24 months after baseline). Insulin resistance was estimated using a validated equation. Cross-sectional and longitudinal multivariate logistic regression models were used to determine the association of plasma vitamin D with insulin resistance, adjusting for potential confounders. RESULTS: Forty-nine per cent of individuals had plasma vitamin D < 50 nmol/l and 26% were insulin resistant. In cross-sectional multivariate analyses, participants who had higher plasma vitamin D (65 nmol/l) had lower odds of prevalent insulin resistance than participants with lower plasma vitamin D (25 nmol/l) (odds ratio 0.70, 95% CI 0.57-0.85). This association was attenuated after additional adjustment for BMI z-score, which could be a confounder or a mediator (odds ratio 0.81, 95% CI 0.64-1.03). In longitudinal multivariate analyses, individuals with higher plasma vitamin D at baseline had lower odds of incident insulin resistance, but this was not significant (odds ratio 0.85, 95% CI 0.63-1.14). CONCLUSIONS: Vitamin Dinsufficiency is common in individuals with Type 1 diabetes and may increase risk for insulin resistance. Additional prospective studies are needed to determine the association between plasma vitamin D and insulin resistance, and to further examine the role of adiposity on this association.
Authors: Ezio Bonifacio; Liping Yu; Alastair K Williams; George S Eisenbarth; Polly J Bingley; Santica M Marcovina; Kerstin Adler; Anette G Ziegler; Patricia W Mueller; Desmond A Schatz; Jeffrey P Krischer; Michael W Steffes; Beena Akolkar Journal: J Clin Endocrinol Metab Date: 2010-05-05 Impact factor: 5.958
Authors: D Dabelea; R B D'Agostino; C C Mason; N West; R F Hamman; E J Mayer-Davis; D Maahs; G Klingensmith; W C Knowler; K Nadeau Journal: Diabetologia Date: 2010-10-01 Impact factor: 10.122
Authors: R J Kuczmarski; C L Ogden; L M Grummer-Strawn; K M Flegal; S S Guo; R Wei; Z Mei; L R Curtin; A F Roche; C L Johnson Journal: Adv Data Date: 2000-06-08
Authors: Sheena Kayaniyil; Reinhold Vieth; Ravi Retnakaran; Julia A Knight; Ying Qi; Hertzel C Gerstein; Bruce A Perkins; Stewart B Harris; Bernard Zinman; Anthony J Hanley Journal: Diabetes Care Date: 2010-03-09 Impact factor: 19.112
Authors: Claudia Gagnon; Zhong X Lu; Dianna J Magliano; David W Dunstan; Jonathan E Shaw; Paul Z Zimmet; Ken Sikaris; Narelle Grantham; Peter R Ebeling; Robin M Daly Journal: Diabetes Care Date: 2011-03-23 Impact factor: 19.112
Authors: Dana Dabelea; Catherine Pihoker; Jennifer W Talton; Ralph B D'Agostino; Wilfred Fujimoto; Georgeanna J Klingensmith; Jean M Lawrence; Barbara Linder; Santica M Marcovina; Elizabeth J Mayer-Davis; Giuseppina Imperatore; Lawrence M Dolan Journal: Diabetes Care Date: 2011-06-02 Impact factor: 19.112
Authors: Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello Journal: Ital J Pediatr Date: 2018-05-08 Impact factor: 2.638
Authors: Archana P Lamichhane; Jamie L Crandell; Lindsay M Jaacks; Sarah C Couch; Jean M Lawrence; Elizabeth J Mayer-Davis Journal: Am J Clin Nutr Date: 2015-05-06 Impact factor: 7.045
Authors: Debika Nandi-Munshi; Maryam Afkarian; Kathryn B Whitlock; Jamie L Crandell; Ronny A Bell; Ralph D'Agostino; Sharon Saydah; Amy K Mottl; Dana Dabelea; Mary Helen Black; Elizabeth J Mayer-Davis; Catherine Pihoker Journal: Horm Res Paediatr Date: 2017-05-29 Impact factor: 2.852
Authors: Marion Muller; Benjamin J Wheeler; Miranda Blackwell; Mathilde Colas; David M Reith; Natalie J Medlicott; Hesham S Al-Sallami Journal: J Diabetes Metab Disord Date: 2018-09-17
Authors: Dana Dabelea; Katherine A Sauder; Elizabeth T Jensen; Amy K Mottl; Alyssa Huang; Catherine Pihoker; Richard F Hamman; Jean Lawrence; Lawrence M Dolan; Ralph D' Agostino; Lynne Wagenknecht; Elizabeth J Mayer-Davis; Santica M Marcovina Journal: Ann N Y Acad Sci Date: 2021-02-05 Impact factor: 6.499
Authors: Richard F Hamman; Ronny A Bell; Dana Dabelea; Ralph B D'Agostino; Lawrence Dolan; Giuseppina Imperatore; Jean M Lawrence; Barbara Linder; Santica M Marcovina; Elizabeth J Mayer-Davis; Catherine Pihoker; Beatriz L Rodriguez; Sharon Saydah Journal: Diabetes Care Date: 2014-12 Impact factor: 19.112
Authors: Katherine A Sauder; Jeanette M Stafford; Natalie S The; Elizabeth J Mayer-Davis; Joan Thomas; Jean M Lawrence; Grace Kim; Karen R Siegel; Elizabeth T Jensen; Amy S Shah; Ralph B D'Agostino; Dana Dabelea Journal: Pediatr Diabetes Date: 2020-08-23 Impact factor: 3.409